Evaluation of Secondary Metabolites (Antibacterial and Antioxidant Activity) of Amlok (Diospyros lotus L) Fruit Extracts of Jammu Region

Anjum Ayoub *

Division of Food Science and Technology, Sher-e-Kashmir University of Agricultural Sciences and Technology, Chatha -180009, Jammu, India.

Jagmohan Singh

Division of Food Science and Technology, Sher-e-Kashmir University of Agricultural Sciences and Technology, Chatha -180009, Jammu, India.

Fozia Hameed

Division of Food Science and Technology, Sher-e-Kashmir University of Agricultural Sciences and Technology, Chatha -180009, Jammu, India.

Muntazir Mushtaq

School of Biotechnology, Sher-e-Kashmir University of Agricultural Sciences and Technology, Chatha -180009, Jammu, India.

*Author to whom correspondence should be addressed.


Abstract

Amlok (Diospyros lotus L.) fruit is growing in the hilly areas of jammu region of Jammu and Kashmir India. It is locally known as amlok. This fruit has black color and small in size and astringent taste. Analysis of the fruit was done quantitatively and qualitatively for various secondary metabolites such as total phenols, quercitin, flavonoids, alkaloids and tannins with the help of various standard methods. It was analyzed that the fruit contains the abundant amount of the tannins as compared to the rest of the metabolites. The antibacterial activity of the fruit extract shows it has great potential to provide defense against wide spectrum infections because of many pathogenic organisms. This fruit can provide defense against many diseases and carcinogenic infections because it contains the higher amount of the antioxidants as reveled with the help of the antioxidant power assay viz, DPPH Scavenging activity.

Keywords: Diospyros lotus, secondary metabolites, antibacterial activity, antioxidant activity.


How to Cite

Ayoub, A., Singh, J., Hameed, F. and Mushtaq, M. (2021) “Evaluation of Secondary Metabolites (Antibacterial and Antioxidant Activity) of Amlok (Diospyros lotus L) Fruit Extracts of Jammu Region”, Journal of Pharmaceutical Research International, 32(42), pp. 8–19. doi: 10.9734/jpri/2020/v32i4231049.